Literature DB >> 6697443

Biochemical microanalysis of glycogen content and glucose-6-phosphate dehydrogenase activity in focal lesions of the rat liver induced by N-nitrosomorpholine.

F Klimek, D Mayer, P Bannasch.   

Abstract

Persisting focal lesions, namely glycogen storage (glycogenotic) foci and mixed cell foci, were induced in liver by treatment of rats with the hepatocarcinogen N-nitrosomorpholine in a concentration of 200 mg/l drinking water for 7 weeks. Four and seven weeks after withdrawal of the carcinogen, the persisting foci were dissected from freeze-dried cryostat sections and their glycogen content and glucose-6-phosphate dehydrogenase activity were analyzed with highly sensitive luminometrical tests. The foci composed exclusively of storage cells contained on an average 100% more glycogen than the surrounding tissue of normal appearance or the liver parenchyma of untreated control animals. The overall glycogen content of the mixed cell foci, which were composed of both glycogenotic and glycogen-poor basophilic cells, was not distinguishable from that of the normal liver tissue. The activity of the G6PDH showed a clear tendency to higher values in the majority of the small glycogen storage foci (up to 100 ng dissected material). However, in larger glycogenotic foci and in particular in the mixed cell foci the activity of this enzyme was significantly higher (by a factor of approximately 3 and 6, respectively) than in the surrounding tissue of normal appearance and in the liver parenchyma of untreated controls. The data support the concept that hepatocarcinogens induce a focal hepatic glycogen storage disease of the liver which appears to elicit adaptive enzymatic changes gradually redirecting the disturbed carbohydrate metabolism towards other metabolic pathways, such as the pentose phosphate pathway.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6697443     DOI: 10.1093/carcin/5.2.265

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  12 in total

Review 1.  Tumor promotion in the liver.

Authors:  R Schulte-Hermann
Journal:  Arch Toxicol       Date:  1985-08       Impact factor: 5.153

2.  Decrease in glucokinase and glucose-6-phosphatase and increase in hexokinase in putative preneoplastic lesions of rat liver.

Authors:  G Fischer; I Ruschenburg; E Eigenbrodt; N Katz
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

Review 3.  Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone.

Authors:  P Bannasch; F Klimek; D Mayer
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

4.  Whole genome amplification of single cells from clinical peripheral blood smears.

Authors:  C P Beltinger; F Klimek; K M Debatin
Journal:  Mol Pathol       Date:  1997-10

5.  Altered liver acini induced in diabetic rats by portal vein islet isografts resemble preneoplastic hepatic foci in their enzymic pattern.

Authors:  F Dombrowski; E Filsinger; P Bannasch; U Pfeifer
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

6.  Histochemical and microbiochemical demonstration of reduced pyruvate kinase activity in thioacetamide-induced neoplastic nodules of rat liver.

Authors:  F Klimek; M A Moore; E Schneider; P Bannasch
Journal:  Histochemistry       Date:  1988

7.  Activity of glycogen synthase and phosphorylase and glucose 6-phosphate content in renal clear cell carcinomas.

Authors:  D Mayer; P Bannasch
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

8.  Over-expression of glucose transporter isoform GLUT1 and hexokinase I in rat renal oncocytic tubules and oncocytomas.

Authors:  Y S Ahn; A Rempel; H Zerban; P Bannasch
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Sequential cellular changes during chemical carcinogenesis.

Authors:  P Bannasch
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

10.  Sequential changes in growth kinetics and cellular phenotype during hepatocarcinogenesis.

Authors:  H Zerban; H M Rabes; P Bannasch
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.